JD HEALTH (6618) Stock Overview

JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. In addition, it is involved in order management, client management, and other merchants operational and maintenance support activities. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. operates as a subsidiary of JD Jiankang Limited.